Search results :

Asenapine

More information: STITCH, PubChem (stereo-specific compounds: 1, 2) and possibly Wikipedia

ATC Code: N05AH05

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4
Somnolence 9.92% - 24% 1.97% - 10% x x x x
Insomnia 1.9% - 16% 5% - 13% x x x
Extrapyramidal symptoms 6% - 12% 2% - 7% x x x
Headache 3.99% - 12% 5.45% - 11% x x x
Akathisia 4% - 12% 2% - 7% x x x x
Vomiting 4% - 7% 5% x x
Hypoaesthesia oral 0.263% - 7% 0% - 1% x x x x
Dizziness 3% - 11% 2% - 4% x x x x
Constipation 1.55% - 7% 2.63% - 6% x x x
Dyspepsia 4% 2% x x
Fatigue 2.75% - 4.65% 1.69% - 3% x x x x
Arthralgia 3% 1% x x
Dysgeusia 3% 1% x x x
Toothache 3% 2% x x
Weight increased 2% - 18.6% 0% - 0.564% x x x x
Oedema peripheral 3% 1% x x
Nausea 2.55% - 3.36% 3.95% x x
Hypertension 2% - 3% 1% - 2% x x
Increased appetite 0% - 4.13% 1% x x x x
Suicidal ideation 2.5% x x
Anxiety 1.1% - 4% 2% - 2.82% x x x x
Schizophrenia 1.84% - 2.75% 2.54% x
Parkinsonism 1.32% - 3.17% 0.94% x
Depression 2% 1% x x
Irritability 1% - 2% 1% x x
Pain in extremity 2% 1% x x
Salivary hypersecretion 1% - 4% 0% x x x x
Dry mouth 1% - 4.74% 1% - 1.41% x x x
Upset stomach 1% - 3% 1% x x
Agitation 1.32% - 2.41% 2.35% x
Tremor 1.23% - 2.22% 1.22% x
Alanine aminotransferase increased 1.17% - 2.02% 0.564% x x
Depressive symptom 1.3% x x
Blister postmarketing x x x
Hypersensitivity postmarketing x x x x
Inflammation postmarketing x x x
Swelling postmarketing x x
Mouth ulceration postmarketing x
Pharyngeal oedema postmarketing x x
Swollen tongue postmarketing x x x x
Localized exfoliation postmarketing x
Agranulocytosis x x
Amenorrhoea x
Anaphylactic shock x
Anaemia x x
Angioedema x x
Mental disorder x x x x
Breast disorder x
Bundle branch block x x x
Connective tissue disorder x x x
Dysphagia x x x
Diabetes mellitus x x
Dysarthria x x x
Dyskinesia x x x
Dyspnoea x x x
Rash x
Extrapyramidal disorder x
Eye disorder x x x
Gastrointestinal disorder x x x x
Glossodynia x x x
Gynaecomastia x
Cardiac disorder x x x
Blood disorder x x x
Hyperglycaemia x x x
Hyperprolactinaemia x x
Hypertriglyceridaemia x x
Hyponatraemia x x
Hypotension x x
Orthostatic hypotension x x x
Immune system disorder x x
Leukopenia x x
Mediastinal disorder x
Muscle rigidity x
Drug withdrawal syndrome neonatal x
Nervous system disorder x x x x
Neuroleptic malignant syndrome x x x
Neutropenia x x x
Pregnancy x
Psychotic disorder x x
Pulmonary embolism x
Restless legs syndrome x
Rhabdomyolysis x
Convulsion x x x
Muscle spasms x x
Suicide x x
Syncope x x x
Tachycardia x x x
Sinus tachycardia x
Thrombocytopenia x x
Ulcer x x
Angiopathy x x x
Wheezing x
Sinus bradycardia x
Electrocardiogram QT prolonged x
Accommodation disorder x x x
Liver injury x x
Malnutrition x x
Sickness x x
Galactorrhoea x
Throat tightness x x
Hepatobiliary disease x
Anaphylactoid reaction x
Movements involuntary x x
Paraesthesia oral x x x x
Sexual dysfunction x
Tardive dyskinesia x x
Increased prolactin level x x
Idiosyncratic drug reaction x x
High cholesterol x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

asenapine maleate / SAPHRIS

Side effects:37
Source:medicines.org.au

asenapine / asenapine maleate 

Side effects:63
Source:EMA

ASENAPINE

Side effects:73
Source:FDA Structured Product Label

Asenapine

Side effects:75
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label